Alzamend Neuro Inc logo

Alzamend Neuro Inc

ALZN | NASDAQ
Chart Builder DCF Calculator
$1.93
-$0.01 (-0.52%)
Sep 22, 2026, 11:20 AM ET · Market open
Fiscal Year
Period Ending
FY 2026
Apr 29, 2026
FY 2025
Apr 29, 2025
FY 2024
Apr 29, 2024
FY 2023
Apr 29, 2023
FY 2022
Apr 29, 2022
FY 2021
Apr 29, 2021
Cash & Equivalents
710.69K 3.95M 376.05K 5.14M 14.06M 1.93M
Short-Term Investments
n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a 0 n/a n/a
Receivables
n/a n/a n/a n/a n/a 16.21K
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
1.05M n/a n/a n/a n/a n/a
Total Current Assets
1.76M 4.18M 455.24K 5.84M 14.41M 2.91M
Property-Plant & Equipment
314.87K 425.61K 176.35K 79.84K 102.91K n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
314.87K 425.61K 176.35K 79.84K 102.91K n/a
Total Assets
2.08M 4.6M 631.59K 5.92M 14.52M 2.91M
Account Payables
1.35M 634.76K 2.93M 2.87M 1.16M 503.59K
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a 300.71K n/a n/a 335.3K
Other Current Liabilities
n/a n/a n/a n/a n/a n/a
Total Current Liabilities
1.35M 634.76K 3.23M 2.87M 1.16M 899.64K
Long-Term Debt
n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a 0 n/a n/a n/a
Total Long-Term Liabilities
n/a n/a 0 n/a n/a n/a
Total Liabilities
1.35M 634.76K 3.23M 2.87M 1.16M 899.64K
Total Debt
n/a n/a 300.71K n/a n/a 335.3K
Book Value
733.21K 3.97M -2.59M 3.05M 13.35M 2.01M
Book Value Per Share
0.22 8.80 -34.51 42.16 202.30 37.40
Common Stock
425 78 69 9.69K 9.55K 6.74K
Retained Earnings
-67.31M -58.54M -54.02M -44.07M -29.19M -16.83M
Comprehensive Income
n/a n/a n/a -14.88M -14.88M -14.88M
Shareholders Equity
733.21K 3.97M -2.59M 3.05M 13.35M 2.01M
Total Investments
n/a n/a n/a n/a n/a n/a

© 2026 bestshares.com. All rights reserved.